PSMA4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.329600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.203800E-01
Normal-vs-Stage2
7.830200E-01
Normal-vs-Stage3
6.435000E-01
Normal-vs-Stage4
2.301400E-01
Stage1-vs-Stage2
7.329200E-01
Stage1-vs-Stage3
8.933200E-01
Stage1-vs-Stage4
5.987400E-01
Stage2-vs-Stage3
6.349200E-01
Stage2-vs-Stage4
3.699800E-01
Stage3-vs-Stage4
7.950000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.403400E-01
Normal-vs-AfricanAmerican
3.277400E-01
Normal-vs-Asian
9.641400E-01
Caucasian-vs-AfricanAmerican
6.441400E-01
Caucasian-vs-Asian
4.796200E-01
AfricanAmerican-vs-Asian
4.062000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.565000E-01
Normal-vs-Female
8.479800E-01
Male-vs-Female
2.758000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.983200E-01
Normal-vs-Age(41-60Yrs)
9.834000E-01
Normal-vs-Age(61-80Yrs)
5.870400E-01
Normal-vs-Age(81-100Yrs)
8.525800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.922400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.752800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.539800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.635800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.582000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.270400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.479800E-01
Normal-vs-Daily Drinker
8.252600E-01
Normal-vs-Weekly Drinker
6.504800E-01
Normal-vs-Occasional Drinker
6.961600E-01
Normal-vs-Social Drinker
3.792200E-01
Non Drinker-vs-Daily Drinker
9.147000E-01
Non Drinker-vs-Weekly Drinker
7.309600E-01
Non Drinker-vs-Occasional Drinker
9.471800E-01
Non Drinker-vs-Social Drinker
5.905000E-01
Daily Drinker-vs-Weekly Drinker
7.088200E-01
Daily Drinker-vs-Occasional Drinker
9.615000E-01
Daily Drinker-vs-Social Drinker
5.857800E-01
Weekly Drinker-vs-Occasional Drinker
6.828600E-01
Weekly Drinker-vs-Social Drinker
9.684200E-01
Occasional Drinker-vs-Social Drinker
5.318800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.773200E-01
Normal-vs-Grade 2
8.822000E-01
Normal-vs-Grade 3
8.864600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.896400E-03
Grade 1-vs-Grade 3
1.654230E-02
Grade 1-vs-Grade 4
7.773200E-01
Grade 2-vs-Grade 3
9.076400E-01
Grade 2-vs-Grade 4
8.822000E-01
Grade 3-vs-Grade 4
8.864600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.169400E-01
Normal-vs-NonDiabetic
7.356800E-01
Diabetic-vs-NonDiabetic
3.921600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.225800E-01
Normal-vs-NoPancreatitis
6.887600E-01
Pancreatitis-vs-NoPancreatitis
1.912010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.719000E-01
Normal-vs-N1
8.091800E-01
N0-vs-N1
6.630200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.911400E-01
Normal-vs-TP53-NonMutant
4.100200E-01
TP53-Mutant-vs-TP53-NonMutant
1.60647999999375E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
